US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist
  • 1.120
  • +0.050+4.67%
Close Feb 14 16:00 ET
  • 1.120
  • 0.0000.00%
Post 20:01 ET
33.46MMarket Cap-0.56P/E (TTM)

About AN2 Therapeutics Company

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

Company Profile

SymbolANTX
Company NameAN2 Therapeutics
Listing DateMar 25, 2022
Issue Price15.00
Founded2017
CEOMr. Eric Easom
MarketNASDAQ
Employees41
Fiscal Year Ends12-31
Address1800 El Camino Real,Suite D
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94027
Phone1-650-331-9090
Websitehttp://www.an2therapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Eric Easom
  • Chief Executive Officer, President and Director
  • 3.34M
  • Kevin Krause
  • Chief Strategy Officer
  • --
  • Dr. Sanjay Chanda, PhD
  • Chief Development Officer
  • --
  • Joshua M. Eizen, J.D.
  • Chief Legal Officer and Chief Operating Officer
  • --
  • Lucy O. Day
  • Chief Financial Officer and Principal Accounting Officer
  • 1.52M
  • Joseph S. Zakrzewski
  • Chairman of the Board
  • 179.64K
  • Dr. Melvin K. Spigelman,M.D.
  • Independent Director
  • 145.64K
  • Kabeer Aziz
  • Independent Director
  • 145.64K
  • Margaret M. FitzPatrick, M.A.
  • Independent Director
  • 142.14K
  • Patricia Martin
  • Independent Director
  • 153.14K
  • Gilbert Lynn Marks
  • Independent Director
  • 145.64K
  • Stephanie Wong
  • Independent Director
  • 157.14K
  • Dr. Rob Readnour, PhD
  • Independent Director
  • 146.14K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!